识别具有高失明和截肢风险的糖尿病患者——一个新的风险评估工具,有助于个体化照护、提供建议、将资源定向于最需要帮助的人群
Identifying people with diabetes at high risk of blindness and amputation -A new risk tool will help to personalise care and advice and to target resources at those in greatest need
摘要
失明和下肢截肢是最令人恐惧的糖尿病并发症。尽管这些并发症的发病率高、对患者的影响很大,但目前缺乏用于识别有极高风险失明和截肢的糖尿病患者的方法。最近Julia Hippisley—Cox和Carol Coupland的研究(见本期第123页;doi:10.1136/bmj.h5441)填补了这一空白,该研究使用的数据来自于QResearch,一个大型临床数据库,源自于英国全科医疗所使用的电子病历记录。
出处
《英国医学杂志中文版》
2016年第3期121-122,共2页
The BMJ Chinese Edition
参考文献12
-
1Hippisley-Cox J, Coupland C. Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study. BMJ 2015; 351:h5441.
-
2Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting car-diovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:1475-82.
-
3ClinRisk. Welcome to the QDiabetes (amputation and blindness)-2015 risk calculator, qdiabetes.org/amputation-blindness/in- dex.php.
-
4UK Prospective Diabetes Study (UKPDS) Group. Intensive blood- glucose control with sulphonylureas or insulin compared with con- ventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
-
5Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16 to 64 years), 1999 to 2000 with 2009 to 2010. BMJ Open 2014;4:e004015.
-
6The Eye Diseases Prevalence Research Group. Causes and preva- lence of visual impairment among adults in the United States. Arch Ophthalmo12004;122:477-85.
-
7Vamos EP, Bottle A, Edmonds ME, Valabhji J, Majeed A, Millett C. Changes in the incidence of lower extremity amputations in indi- viduals with and without diabetes in England between 2004 and 2008. Diabetes Care 2010;33:2592-7.
-
8Diabetes UK. More than 135 diabetes amputations every week. 2015. www.diabetes.org.uk/About us/News/More-than- 135- diabe- tes-amputations-every-week/.
-
9Meltzer D, Egleston B. How patients with diabetes perceive their risk for major complications. Eft Clin Pract 2000;3:7-15.
-
10Ham C. The three crises facing the NHS in England. BMJ 2015; 351:h5495.
-
1廖振润.全科医疗干预原发性高血压病患者的临床效果分析[J].当代医学,2013,19(36):43-44. 被引量:7
-
2陶家驹.支气管哮喘的全科医疗[J].中国全科医学,1998,1(3):135-136. 被引量:6
-
3刘旭霞.全科医疗干预原发性高血压病的临床观察[J].大家健康(学术版),2015(7):93-94.
-
4吴汝莲.高血压病的全科医疗[J].中国全科医学,1999,2(1):3-5. 被引量:48
-
5吴玉华.高血压患者56例全科医疗干预治疗效果观察[J].当代医学,2016,22(12):110-111.
-
6张爱珍.糖尿病的全科医疗[J].中国全科医学,1998,1(2):67-69. 被引量:17
-
7李剑.全科医疗干预原发性高血压病46例临床观察[J].浙江中西医结合杂志,2012,22(4):269-271. 被引量:6
-
8杨丽莉.高血压病的全科医疗[J].养生保健指南(医药研究),2016,0(6):198-198. 被引量:1
-
9赵承敏.高血压病的全科医疗[J].职业卫生与病伤,2003,18(2):143-144. 被引量:3
-
10成海斌.原发性高血压的全科医疗干预[J].当代医学,2012,18(35):155-156. 被引量:4